uap

All the patients with UAP were ranked according to clinical risk level .

对UAP进行临床危险度分层。

The data is sent to the UAP Insurance Company .

数据发往UAP保险公司。

Clinical Evaluation on the Effects of Ligustrazine Injection in 65 Cases Aged with UAP

川芎嗪注射液治疗老年不稳定心绞痛65例临床观察

Conclusions : Low molecular heparin is effective and safety in the treatment of UAP .

结论：低分子肝素是治疗UAP的一种安全、有效的药物。

5 , To follow up the group of UAP for 3-6 months .

对不稳定性心绞痛患者进行3-6个月的随访。

Method : A retrospective analysis of three treatment projects of UAP was made by using the cost-effectiveness analysis .

方法：应用药物经济学的成本-效果分析方法，对三种不稳定性心绞痛治疗方案的疗效进行回顾性分析评价。

Conclusions The serum levels of inflammatory makers in the UAP are significantly increased .

结论UAP患者各炎性指标水平显著性增高；

The correlation between coping style and psychological status was different in UAP and AMI patients .

两组患者不同的应对方式（面对、回避、屈服）与心理状况的不同维度（自主健康感、无能为力感、沮丧感、社交障碍感）之间的相关性也有所不同。

Methods The serum cTnI and CK-MB level of 91 UAP patients were determined .

方法测定91例UAP患者血清cTnI、磷酸肌酸激酶同工酶（CK-MB）的含量。

Objective : To investigate the economics consequences of low molecular heparin in the treatment of UAP .

前言：目的：探讨三种低分子肝素钙治疗不稳定性心绞痛的经济效果。

NSTEMI group was significantly higher than UAP group ( p0.01 ) . 4 .

NSTEMI组非常显著高于UAP组（p0.01）。

The age and sex were matched in UAP ( including subgroup ) and the control group .

各组年龄、性别组成相匹配。

The relation of plasma vasoactive peptide concentration with UAP

不稳定性心绞痛与血管活性肽的相关性

Recently , percutaneous coronary intervention ( PCI ) has been used to treat UAP .

近年来，经皮冠状动脉腔内介入治疗（PercutaneousCoronaryIntervention，PCI）已应用于不稳定性心绞痛的治疗中。

Conclusion Captopril enhances the endogenous fibrinolytic system in patients with AMI and UAP .

结论卡托普利增强冠心病患者内源性纤溶系统活性。

To present several key technologies that should be adopted first and also give further description on UAP and DRM .

提出了应优先发展的媒体格式转换、UAP和DRM等几项关键技术。并对UAP和DRM技术进行了进一步的分析和说明。

Conclusions Lipid lowering therapy in patients with UAP has antiinflammatory effect on vascular endothelium .

结论UAP调脂治疗具有抗血管内皮炎症反应的作用，并独立于降脂之外。

Patients with UAP ⅱ,ⅲ grade need to use low molecular heparin to decrease long term acute cardial events .

对Ⅱ级、Ⅲ级患者，均需要予以低分子肝素强化治疗，以减少远期患者的急性心血管事件。

Conclusion Expression of CD11b in leucocytes in UAP is higher than SAP .

结论不稳定心绞痛单核细胞及中性粒细胞CD11b表达均显著高于稳定心绞痛。

Conclusions : The patients with UAP accompanied with IGT have the state of the high activity of platelet .

结论：UAP合并IGT患者存在血小板活化状态。

Objective : To investigate the effects of humanistic nursing on unstable angina pectoris ( UAP ) .

目的：探讨人性化护理对不稳定型心绞痛患者治疗的影响。

Conclusion : The disorder of coagulation and fibrinolysis plays an important role in the pathogenesis of UAP .

结论：UAP患者存在凝血、纤维功能凝血的失调。

The relationship between changes of EGG and angiograms in UAP has contrasted .

对比分析UAP胸痛时ECG动态缺血性ST-T变化与冠状动脉造影结果。

Conclusion Serum cTnI level is an important biochemical indicator on the risk grading and prognosis estimation of UAP patients .

结论血清cTnI是UAP患者危险度分层及判断预后的重要生化指标。

Objective To observe the clinical effection of treating the UAP with Herbesser .

目的观察合贝爽治疗不稳定性心绞痛的临床疗效。

Blood samples were obtained from venous at the next morning after admission of the patients of SAP , UAP and control groups .

SAP、UAP、对照组患者均于入院第二天清晨取空腹静脉血，心肌梗死患者于入院后即刻抽取静脉血，保证发病至采血的时间在6小时内。

AIM : To study the effect of small dose of heparin calcium in treatment of unstable angina pectoris ( UAP ) .

目的：了解小剂量肝素钙治疗不稳定性心绞痛（UAP）的作用。

There were statistical differences in SEM between UAP group and stable angina pectoris and normal control groups ( P < 0.01 ) .

75.0%SEM值减小，与正常对照组、稳定性心绞痛组对比，差异具有统计学意义（P<0.01）。

Conclusion : There were obvious differences in TnT changes in UAP , non Q wave and Q wave acute myocardial infarction .

结论：UAP患者TnT的变化与非Q波型AMI和Q波型AMI有显著的不同。

The Effect of Low-molecular-weight Heparin Natrum and Defibrase in Treatment of UAP

低分子肝素钠与降纤酶治疗不稳定心绞痛的疗效